Chuck Royce (Royce & Associates) add Catalyst Pharmaceuticals, Inc.
Chuck Royce (Royce & Associates) add $40.2M of disclosed value in Catalyst Pharmaceuticals, Inc..
Signal
Investor Move
Action
Add
Capital
$40.2M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.